Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

Di cosa tratta questo bando?

The call funds research on the costs, organisation and outcomes of cancer control so that health systems can deliver more equitable and cost-effective care. Research should involve people at risk of cancer, cancer patients and their caregivers.

Cosa finanzia questo bando?

Scope

Proposals should address all of the following:

• Establish, validate or refine methods and models in health economics, health systems, epidemiological or outcomes research to carry out cost-effectiveness and epidemiological analyses that benefit people at risk of cancer and cancer patients.
• Take account of socio-economic inequalities and socio-demographic, organisational and cultural trends, involving people at risk, patients and caregivers through participative research.
• Calculate cancer-control healthcare expenditure and its relation to value-driven care, reflecting local, regional and national differences across EU Member States and Associated Countries.
• Demonstrate how access to and organisation of evidence-based, cost-effective cancer control programmes can be improved in cancer centres, hospitals, at home or in community settings.

Expected outcomes

• People at risk of cancer, patients and caregivers gain access to more effective and cost-effective cancer control programmes.
• Researchers, physicians, innovators and SMEs gain access to data on healthcare spending, such as expenditure, prescriptions, drug pricing, reimbursement and registry data.
• Health systems and policymakers obtain evidence to improve equitable outcomes, address direct and indirect costs and deliver value-driven cancer care.

Collaboration

Projects should build on the resources of the Knowledge Centre on Cancer and join the Cancer Mission "Understanding" cluster, with budget for networking and joint activities.

Quando scade il bando?

16 settembre 2027 (314 giorni)

21 September 2027 (single-stage)